CollPlant Biotechnologies
CLGN
16 hedge funds and large institutions have $3.33M invested in CollPlant Biotechnologies in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 0 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
14% more funds holding
Funds holding: 14 → 16 (+2)
0.16% more ownership
Funds ownership: 11.12% → 11.28% (+0.16%)
27% less capital invested
Capital invested by funds: $4.59M → $3.33M (-$1.25M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WPC
Waters Parkerson & Co
New Orleans,
Louisiana
|
+$46.7K |
| 2 |
AE
AMH Equity
Great Neck,
New York
|
+$30K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$10.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.58K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.76K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Brown Advisory
Baltimore,
Maryland
|
-$29.1K |
| 2 |
PA
Pinnacle Associates
New York
|
-$1.76K |
| 3 |
Renaissance Technologies
New York
|
-$1.06K |
CLGN Hedge Fund Activity: Q1 2025 in Review
16 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in CollPlant Biotechnologies (CLGN) for Q1 2025, worth a combined $3.33M — down 27% from $4.59M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CLGN positions and 0 closed out — a net gain of 2 holders — while 5 added to existing stakes and 3 trimmed.
The largest buyer was Waters Parkerson & Co, opening a new position worth an estimated $46.7K. The largest seller was Brown Advisory, cutting an estimated $29.1K.
- 16 institutional investors held CollPlant Biotechnologies (CLGN) as of Q1 2025, up from 14 in Q4 2024.
- Funds reported $3.33M of CollPlant Biotechnologies stock for Q1 2025, down 27% quarter-over-quarter.
- 2 funds opened new CollPlant Biotechnologies positions in Q1 2025 and 0 closed out, a net change of +2 holders.
- The largest CollPlant Biotechnologies buyer in Q1 2025 was Waters Parkerson & Co, an estimated $46.7K added.
- The largest CollPlant Biotechnologies seller in Q1 2025 was Brown Advisory, an estimated $29.1K sold.
Based on aggregated 13F filings for Q1 2025.